MinuteCE®

A robust collection of short-form, digestible CE activities that are made to fit into any schedule. With MinuteCE, you’re in control of the content you want, when you want it. To start microlearning, follow these simple steps:

Step 1: Select the episodes & 1-minute challenges you'd like to consume

Step 2: Bank time as you blaze your way through the program

Step 3: Claim credit once available as shown in the Progress Bar

Step 4: Track the status of credits claimed in your profile

Why choose microlearning?

Bite-sized episodes
The most relevant content
Improved retention

To experience MinuteCE for yourself, select one of the episodes below to start learning!

10633

LikeLikedUnlike

Episodes 1-15 of 566

MinuteCE®
Metastatic Pancreatic Ductal Adenocarcinoma (PDAC): From Diagnosis to Treatment
- Efrat Dotan, MD
  Peer
- Shubham Pant, MD, MBBS
  Peer
0.25 credits 2 episodes
Diagnosis and Management of Metastatic PDAC
MinuteCE®
Diagnosis and Management of Metastatic PDAC
- Efrat Dotan, MD
  Peer
- Shubham Pant, MD, MBBS
  Peer
0.25 program credits
Chemotherapy Strategies for Metastatic PDAC
MinuteCE®
Chemotherapy Strategies for Metastatic PDAC
- Efrat Dotan, MD
  Peer
- Shubham Pant, MD, MBBS
  Peer
0.25 program credits
MinuteCE®
Idiopathic Multicentric Castleman Disease Patient Journey: Optimizing Best Practices to Improve Patient-Centric Outcomes
- Corey Casper, MD, MPH
  Peer
- Sudipto Mukherjee, MD, PhD, MPH
  Peer
- Jovanna De La Pena
  Peer
1.00 credits 9 episodes
Recent Guidelines Updates: Implications to Practice
MinuteCE®
Recent Guidelines Updates: Implications to Practice
- Sudipto Mukherjee, MD, PhD, MPH
  Peer
1.00 program credits
A Global Health Crisis
MinuteCE®
A Global Health Crisis
- Donna Ryan, MD
  Peer
1.25 program credits
MinuteCE®
Innovations in Oncology Learning Center From Guidelines to Practice: Gastrointestinal Cancers
- Sara Lonardi, MD
  Peer
- Aparna R. Parikh, MD
  Peer
- Alan Venook, MD
  Peer
1.25 credits 10 episodes
Applying Current Guidelines in the First-Line Treatment of MSI-H/dMMR mCRC—A Case Discussion
MinuteCE®
Applying Current Guidelines in the First-Line Treatment of MSI-H/dMMR mCRC—A Case Discussion
- Aparna R. Parikh, MD
  Peer
1.25 program credits
Expert Viewpoint: Optimizing Breast Cancer Treatment
MinuteCE®
Expert Viewpoint: Optimizing Breast Cancer Treatment
- William J. Gradishar, MD
  Peer
- Erica L. Mayer, MD, MPH
  Peer
- Peter Schmid, FRCP, MD, PhD
  Peer
1.50 program credits
Adjuvant Treatments for HR+/HER2- EBC: The Role of CDK4/6 and PARP Inhibitors
MinuteCE®
Adjuvant Treatments for HR+/HER2- EBC: The Role of CDK4/6 and PARP Inhibitors
- Erica L. Mayer, MD, MPH
  Peer
1.50 program credits
Guideline Recommendations for the Definition and Treatment of HER2-Low Breast Cancer
MinuteCE®
Guideline Recommendations for the Definition and Treatment of HER2-Low Breast Cancer
- Erica L. Mayer, MD, MPH
  Peer
1.50 program credits
Clinical Implications of Current Guidelines on First-Line Immunotherapy and PARP Inhibitors for TNBC
MinuteCE®
Clinical Implications of Current Guidelines on First-Line Immunotherapy and PARP Inhibitors for TNBC
- Peter Schmid, FRCP, MD, PhD
  Peer
1.50 program credits
Immunotherapy-Based Approaches for First-Line Treatment of Advanced HCC: The Evidence
MinuteCE®
Immunotherapy-Based Approaches for First-Line Treatment of Advanced HCC: The Evidence
- Alan Venook, MD
  Peer
1.25 program credits
Emerging Directions in Biomarker-Directed Therapy for GI Malignancies
MinuteCE®
Emerging Directions in Biomarker-Directed Therapy for GI Malignancies
- Alan Venook, MD
  Peer
1.25 program credits
Biomarker-Directed Approaches for Frontline Treatment of Advanced Gastric/GEJ Cancers: The Evidence
MinuteCE®
Biomarker-Directed Approaches for Frontline Treatment of Advanced Gastric/GEJ Cancers: The Evidence
- Sara Lonardi, MD
  Peer
1.25 program credits

Program Chapters

Segment Chapters

Playlist:

Recommended